Loading...

Bioventus Inc.

BVS•NASDAQ
Healthcare
Medical - Devices
$10.09
$0.38(3.91%)
U.S. Market opens in 30h 27m

Bioventus Inc. (BVS) Stock Overview

Explore Bioventus Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap679.7M
P/E Ratio29.19
EPS (TTM)$0.33
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$7.45
3 Months$7.82
1 Year Target$6.22

BVS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bioventus Inc. (BVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.22.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.19 and a market capitalization of 679.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.91%
5-Day Change
-5.79%
1-Month Change
10.27%
3-Month Change
25.81%
6-Month Change
45.39%
Year-to-Date (YTD) Change
35.62%
1-Year Change
30.53%
3-Year Change
889.22%
5-Year Change
-29.29%
All-Time (Max) Change
-47.48%

Contact Information

https://www.bioventus.com
919 474 6700
4721 Emperor Boulevard, Durham, NC, 27703

Company Facts

930 Employees
IPO DateFeb 11, 2021
CountryUS
Actively Trading

Frequently Asked Questions